| Bioactivity | Lanopepden mesylate (GSK 1322322 mesylate) is a peptide deformase (PDF) inhibitor. Lanopepden mesylate has antibacterial activity by inhibiting the activity of PDF, preventing the correct synthesis of bacterial proteins. Lanopepden mesylate mainly targets Gram-positive bacteria. Lanopepden mesylate can be used in the study of acute bacterial skin and skin structural infections, as well as for novel antibiotic mechanisms of action and the development of novel strategies against drug-resistant bacteria[1]. |
| CAS | 1441390-17-5 |
| Formula | C23H38FN7O7S |
| Molar Mass | 575.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee H Y, et al. Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria[J]. Bioorganic & Medicinal Chemistry Letters, 2016, 26(13): 3148-3152. |
Lanopepden mesylate
CAS: 1441390-17-5 F: C23H38FN7O7S W: 575.65
Lanopepden mesylate (GSK 1322322 mesylate) is a peptide deformase (PDF) inhibitor. Lanopepden mesylate has antibacterial
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.